Super Bugs and Other Emerging Hazards
NFPA 1999, with its 2008 edition just released, covers protection from new hazards that include MRSA and H5N1.
- By Donald F. Groce
- Apr 07, 2008
It seems that each year, new hazards in
the home, workplace, and community
are identified that endanger our health
and well-being. Bloodborne pathogens
such as bird flu and the mutant bacterial
staph, MRSA, continue to threaten our
health. New toxicity hazards have been discovered
in chemicals that have been used
for decades. We must constantly be aware
of the hazards and take the proper precautions,
both professionally and personally.
Super-Bugs
News of pathogenic microorganisms that
threaten our existence is reported globally
each day. Although avian influenza, the
H5N1 virus, has not yet mutated into a
form that is contagious in humans, it still
wreaks havoc in many countries around
the world. The World Health Organization
has recorded outbreaks in about 60
countries that have affected bird populations
and have killed 232 people. The
countries with the highest numbers of
deaths have been Vietnam and Indonesia,
with 155 deaths.
MRSA
A mutated form of the common bacteria,
staph, is spreading throughout the United
States. MRSA, Methicillin Resistant
Staphylococcus Aureus, has emerged after
decades of prescribing penicillin-based
antibiotics. This Super-Bug that is very difficult
to kill has emerged and is spreading.
What is MRSA?
The U.S. Centers for Disease Control and
Prevention estimates MRSA will cause
more deaths than AIDS this year. This
shocking statistic, which CDC published
recently, emphasizes the changing face of
our health concerns and the need for constantly
monitoring and educating the
public about emerging trends in toxicity
and infectious diseases. Staph is a common
bacterium that is carried by 25-30 percent
of the population and lives on their skin or
in their noses.
Years of prescribing and overprescribing
prescription antibiotics have
resulted in mutation of staph into a virulent
form that resists common antibiotics
and causes severe, sometimes disfiguring
skin infections that can spread to other
body systems and may cause fatal infections.
Hospital Acquired (HA-MRSA) has
been a problem in hospitals and nursing
homes for years. Community Acquired
MRSA has now surfaced and is in the
headlines every day.
Clusters of cases of MRSA outbreaks
have been reported in athletes, military
recruits, children, and certain ethnic
groups. Law enforcement personnel who
deal with homeless people, illegal immigrants,
and prison inmates are at risk of
acquiring MRSA.
What does it look like, and how is it
prevented?
MRSA infections are commonly mistaken
for spider bites, boils, or pimples. They
spread and can be disfiguring and require
surgery, or even amputation, to stop. Systemic
involvement can result in death.
MRSA can penetrate through a scrape,
pimple, or sore. Most MRSA is spread on
hands to different surfaces.
Proper hand washing is the most
important step in preventing transmission
and infection by MRSA. You should never
share personal items such as towels and
razors or touch anyone’s bandages or
wounds. Towels and gym clothes should be
washed in hot water and dried in hot
dryers, not air-dried. Surfaces should be
wiped down with alcohol-based disinfectants
that are known to kill MRSA. Hand
sanitizers that are alcohol based and proven
to kill MRSA should be used to prevent
transmission and infection.
Does anything treat MRSA?
Some antibiotics such as Vancomycin are
effective for treating MRSA, but common
penicillin-based antibiotics are not effective.
You should contact your doctor if you
suspect you have MRSA as soon as possible.
Earlier diagnosis is the key to successful
treatment.
Personal Protective Equipment
and NFPA 1999 Compliance
Writing professional standards designed
to protect workers and communities from
exposure to chemical and biological
agents is a time-consuming and laborintensive
process that is not for everyone.
It is comforting to know that certain standards-
writing organizations have the foresight
to have addressed many of these
issues before they arise.
NFPA 1999 is an example. Even protection
from new hazards such as MRSA
and avian influenza hazards is covered by
NFPA 1999, Standard on Protective
Clothing for Emergency Medical Operations,
which was originally written to
address the protection of first responders
such as firefighters and emergency medical
operations personnel from exposure to
bloodborne pathogens. All of the PPE covered
in the standard was required to provide
the minimal level of protection from
bloodborne pathogens and included
gloves, garments, faceshields or masks, eye
protection, and mouth pieces or other ventilation
devices.
In February 2006, the U.S. Department
of Homeland Security recognized
the necessity of standardization of the
PPE for first responders that is purchased
using DHS grant money. Five existing
NFPA standards were accepted as the
minimal criteria for protective equipment;
one of these accepted standards is NFPA
1999. It was written referencing 21 different
ASTM performance standards. For gloves, the standard includes rubber properties,
puncture resistance, viral penetration
resistance, and protein levels. This is
the only industry standard that requires
that latex proteins be below 50 micrograms
per gram.
In order to pass the testing for compliance
with NFPA 1999, protective items
including gloves must pass ASTM F 1671,
Standard Test Method for Resistance of
Materials Used in Protective Clothing to
Penetration by Blood-Borne Pathogens
Using Phi-X174 Bacteriophage Penetration
as a Test System. Bacteriophage Phi-
X174 is the model viral particle utilized for
testing for protection from bloodborne
pathogens. This model virus is 27 nanometers
in size and is in fact much smaller than
anthrax, MRSA bacteria, SARS, HIV,
H5N1 avian influenza, and even Hepatitis
B virus. This tiny nanoparticle is the ideal
choice for testing whether bloodborne
pathogens will penetrate personal protective
equipment because of its size and the
fact that it is a nonpathogenic viral entity.
Gloves and MRSA Transmission
It should be noted that an item such as a
disposable glove will protect the wearer
from exposure of the hands to MRSA bacteria.
However, MRSA can contaminate
the outer surface of any glove and be
transmitted to other surfaces. The wearer
can wipe the glove surface with hand sanitizers
that kill MRSA to prevent transmission
of MRSA on the surface of the
glove. You must be certain you are using a
hand sanitizer that has been proven to kill
MRSA and that the sanitizer is not
degrading the glove that is worn so that
the barrier efficacy is compromised. Also,
gloves provide protection from bloodborne
pathogens and are an integral part
of a protection ensemble for contact with
MRSA, whether treating patients or
cleaning up facilities, but they should not
be the sole item of PPE chosen for such
virulent pathogens.
NFPA 1999’s 2008 Edition
The latest version of NFPA 1999 has just
been published and includes revisions,
addition of more requirements, and more
PPE items.
The 2008 edition still has all of the
requirements of the old version and now
includes the addition of reusable PPE performance
and certification requirements.
The reusable PPE must pass more stringent
physical testing than the disposable,
single-use items, such as multiple washing
in addition to the viral penetration resistance
and physical properties. Footwear
performance has also been added, as have
respirator requirements and helmets. The
2008 edition references 37 ASTM test
methods for performance requirements,
two European tests, four American Association
of Textile Chemists and Colorists
tests, and three ANSI tests.
The new version of the standard also
addresses PPE for first responders and first
receivers from exposure to CBRN agents.
This Chemical, Biological, Radiological,
and Nuclear protection is included to
equip the firefighters and emergency medical
personnel who are first responders in
the event of a terrorist attack.
This article originally appeared in the April 2008 issue of Occupational Health & Safety.